Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2019 Filed Sep 9, 2019 15:59 UTC Amendment |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 3,808 | $113.69 | $432,931.52 |
DisclosureSEC source: 0000059478-19-000246 · wf-form4a_156804473200793.xml · nonDerivative · entry 2 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,806 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019. F3 · price: This transaction is being amended to correct the price range reported on the Form 4 filed on 09/04/19. This transaction was executed in multiple trades at prices ranging from $113.50 to $113.85. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2019 Filed Sep 9, 2019 15:59 UTC Amendment |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 11,192 | $112.88 | $1,263,352.96 |
DisclosureSEC source: 0000059478-19-000246 · wf-form4a_156804473200793.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,614 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019. F2 · price: This transaction is being amended to correct the price range reported on the Form 4 filed on 09/04/19. This transaction was executed in multiple trades at prices ranging from $112.50 to $113.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 13:42 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 97 | $112.53 | $10,915.41 |
DisclosureSEC source: 0000059478-19-000234 · wf-form4_156639491489417.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,494 Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 13:45 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 121 | $112.53 | $13,616.13 |
DisclosureSEC source: 0000059478-19-000236 · wf-form4_156639509538589.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,038 Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 13:47 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 18 | $112.53 | $2,025.54 |
DisclosureSEC source: 0000059478-19-000238 · wf-form4_156639525736706.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,481 Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 13:50 UTC |
Walker KarenDirector
|
GrantCommon Stock | 110 | $112.53 | $12,378.30 |
DisclosureSEC source: 0000059478-19-000240 · wf-form4_156639539372994.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937 Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 19:46 UTC |
Smiley Joshua LSVP and CFO
|
PurchaseCommon Stock | 185 | $108.47 | $20,066.95 |
DisclosureSEC source: 0000059478-19-000218 · wf-form4_156321999834580.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,595 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $108.00 to $109.09. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 15:16 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 101 | $108.47 | $10,955.47 |
DisclosureSEC source: 0000059478-19-000220 · wf-form4_156329017328354.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,397 Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 15:19 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 125 | $108.47 | $13,558.75 |
DisclosureSEC source: 0000059478-19-000222 · wf-form4_156329033066083.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,917 Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 15:22 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 19 | $108.47 | $2,060.93 |
DisclosureSEC source: 0000059478-19-000224 · wf-form4_156329050648674.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,463 Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 15:24 UTC |
Walker KarenDirector
|
GrantCommon Stock | 114 | $108.47 | $12,365.58 |
DisclosureSEC source: 0000059478-19-000226 · wf-form4_156329066636023.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827 Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 19:57 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000214 · wf-form4_156261581139152.xml · derivative · entry 3 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,468 Underlying: Common Stock · 2,394 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in three installments, 2,394 on July 5, 2018, 2,394 on July 5, 2019, and 2,468 on July 5, 2020. F2 · derivative.expiration_date: The Restricted Stock Units vest in three installments, 2,394 on July 5, 2018, 2,394 on July 5, 2019, and 2,468 on July 5, 2020. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 19:57 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
Tax withholdingCommon Stock | 1,080 | $114.42 | $123,573.60 |
DisclosureSEC source: 0000059478-19-000214 · wf-form4_156261581139152.xml · nonDerivative · entry 2 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,956 Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 19:57 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
Exercise / conversionCommon Stock | 2,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000214 · wf-form4_156261581139152.xml · nonDerivative · entry 1 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 19:34 UTC |
Walker KarenDirector
|
GrantCommon Stock | 87 | $113.40 | $9,865.80 |
DisclosureSEC source: 0000059478-19-000206 · wf-form4_156088644161457.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713 Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 19:35 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 18 | $113.40 | $2,041.20 |
DisclosureSEC source: 0000059478-19-000207 · wf-form4_156088650351205.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,444 Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 19:36 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 120 | $113.40 | $13,608.00 |
DisclosureSEC source: 0000059478-19-000208 · wf-form4_156088658146902.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,792 Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 19:38 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 96 | $113.40 | $10,886.40 |
DisclosureSEC source: 0000059478-19-000209 · wf-form4_156088669537013.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,296 Read SEC document |
| June 05, 2019 Filed Jun 5, 2019 18:15 UTC |
Smiley Joshua LSVP and CFO
|
PurchaseCommon Stock | 426 | $118.03 | $50,280.78 |
DisclosureSEC source: 0000059478-19-000201 · wf-form4_155975850983762.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,410 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 17:57 UTC |
Harrington Michael JSenior VP and General Counsel
|
SaleCommon Stock | 16,000 | $116.72 | $1,867,520.00 |
DisclosureSEC source: 0000059478-19-000199 · wf-form4_155967100770907.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,300 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $116.36 to $117.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 20, 2019 Filed May 22, 2019 12:23 UTC |
Walker KarenDirector
|
GrantCommon Stock | 171 | $116.23 | $19,875.33 |
DisclosureSEC source: 0000059478-19-000194 · wf-form4_155852777050319.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623 Read SEC document |
| May 20, 2019 Filed May 22, 2019 12:24 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 17 | $116.23 | $1,975.91 |
DisclosureSEC source: 0000059478-19-000195 · wf-form4_155852788100301.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,366 Read SEC document |
| May 20, 2019 Filed May 22, 2019 12:27 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 117 | $116.23 | $13,598.91 |
DisclosureSEC source: 0000059478-19-000196 · wf-form4_155852801381418.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,624 Read SEC document |
| May 20, 2019 Filed May 22, 2019 12:28 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 94 | $116.23 | $10,925.62 |
DisclosureSEC source: 0000059478-19-000197 · wf-form4_155852810377887.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,952 Read SEC document |
| May 03, 2019 Filed May 7, 2019 18:18 UTC |
Shaw ChristiSVP and Pres., Lilly Bio-Meds
|
SaleCommon Stock | 500 | $117.99 | $58,995.00 |
DisclosureSEC source: 0000059478-19-000183 · wf-form4_155725307162586.xml · nonDerivative · entry 2 Shaw Christi · CIK 0001702473 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $117.82 to $118.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 03, 2019 Filed May 7, 2019 18:18 UTC |
Shaw ChristiSVP and Pres., Lilly Bio-Meds
|
SaleCommon Stock | 7,077 | $117.08 | $828,575.16 |
DisclosureSEC source: 0000059478-19-000183 · wf-form4_155725307162586.xml · nonDerivative · entry 1 Shaw Christi · CIK 0001702473 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 03, 2019 Filed May 16, 2019 20:44 UTC Amendment |
Shaw ChristiSVP and Pres., Lilly Bio-Meds
|
SaleCommon Stock | 7,077 | $117.08 | $828,575.16 |
DisclosureSEC source: 0000059478-19-000189 · wf-form4a_155803944803676.xml · nonDerivative · entry 1 Shaw Christi · CIK 0001702473 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · security: This amendment is being filed solely to gain access to the filing system in order to attach the power of attorney authorization. This line item is being re-reported for this purpose. F2 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:04 UTC |
Shaw ChristiSVP and Pres., Lilly Bio-Meds
|
Exercise / conversionRestricted Stock Unit · Derivative | 13,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000181 · wf-form4_155691382911366.xml · derivative · entry 3 Shaw Christi · CIK 0001702473 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,750 shares Expires 2019-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vested in two equal installments on May 1, 2018 and May 1, 2019. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:04 UTC |
Shaw ChristiSVP and Pres., Lilly Bio-Meds
|
Tax withholdingCommon Stock | 6,173 | $117.04 | $722,487.92 |
DisclosureSEC source: 0000059478-19-000181 · wf-form4_155691382911366.xml · nonDerivative · entry 2 Shaw Christi · CIK 0001702473 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,577 Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:04 UTC |
Shaw ChristiSVP and Pres., Lilly Bio-Meds
|
Exercise / conversionCommon Stock | 13,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000181 · wf-form4_155691382911366.xml · nonDerivative · entry 1 Shaw Christi · CIK 0001702473 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:57 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 88 | $124.08 | $10,919.04 |
DisclosureSEC source: 0000059478-19-000159 · wf-form4_155552742943767.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,858 Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 19:35 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 86 | $124.08 | $10,670.88 |
DisclosureSEC source: 0000059478-19-000161 · wf-form4_155552969858464.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,507 Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 19:41 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 55 | $124.08 | $6,824.40 |
DisclosureSEC source: 0000059478-19-000163 · wf-form4_155553008465796.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,645 Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 19:45 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 16 | $124.08 | $1,985.28 |
DisclosureSEC source: 0000059478-19-000165 · wf-form4_155553033182308.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,349 Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 19:49 UTC |
Walker KarenDirector
|
GrantCommon Stock | 80 | $124.08 | $9,926.40 |
DisclosureSEC source: 0000059478-19-000167 · wf-form4_155553052855423.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452 Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 18:36 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
SaleCommon Stock | 4,735 | $125.15 | $592,585.25 |
DisclosureSEC source: 0000059478-19-000155 · wf-form4_155543979771441.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,085 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 18:48 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
SaleCommon Stock | 10,000 | $124.65 | $1,246,500.00 |
DisclosureSEC source: 0000059478-19-000157 · wf-form4_155544046907704.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,806 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $124.22 to $125.00. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 18:54 UTC |
Shah Aarti S.SVP & CIO
|
SaleCommon Stock | 1,800 | $125.85 | $226,530.00 |
DisclosureSEC source: 0000059478-19-000153 · wf-form4_155474967555852.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,425 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2019. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 18:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,714 | $132.02 | $490,311.14 |
DisclosureSEC source: 0001209191-19-021409 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,810,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.0153 to $132.0211, inclusive. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 18:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 201,286 | $131.40 | $26,448,376.54 |
DisclosureSEC source: 0001209191-19-021409 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,814,018 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.00 to $131.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 19:16 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 1,000 | $128.50 | $128,500.00 |
DisclosureSEC source: 0000059478-19-000151 · wf-form4_155328215446512.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,595 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 18:10 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 87 | $125.24 | $10,895.88 |
DisclosureSEC source: 0000059478-19-000134 · wf-form4_155310540294669.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,770 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 18:17 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 85 | $125.24 | $10,645.40 |
DisclosureSEC source: 0000059478-19-000136 · wf-form4_155310583142708.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,421 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 18:37 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 54 | $125.24 | $6,762.96 |
DisclosureSEC source: 0000059478-19-000138 · wf-form4_155310703973960.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,590 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 18:41 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 16 | $125.24 | $2,003.84 |
DisclosureSEC source: 0000059478-19-000140 · wf-form4_155310729316011.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,333 Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 18:46 UTC |
Walker KarenDirector
|
GrantCommon Stock | 79 | $125.24 | $9,893.96 |
DisclosureSEC source: 0000059478-19-000142 · wf-form4_155310756192102.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372 Read SEC document |
| March 15, 2019 Filed Apr 16, 2019 18:36 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 1,815 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000155 · wf-form4_155543979771441.xml · nonDerivative · entry 2 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,270 Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 16:47 UTC |
Fry Stephen FSVP, HR & Diversity
|
SaleCommon Stock | 14,847 | $123.16 | $1,828,556.52 |
DisclosureSEC source: 0000059478-19-000129 · wf-form4_155249564059588.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,663 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $122.68 to $123.41. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 07, 2019 Filed Feb 3, 2020 21:50 UTC |
Norton JohnaSenior VP, Global Quality
|
GiftCommon Stock | 196 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000014 · wf-form5_158076658467404.xml · nonDerivative · entry 1 Norton Johna · CIK 0001702471 · Senior VP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,623 Read SEC document |
| March 06, 2019 Filed Apr 8, 2019 18:54 UTC |
Shah Aarti S.SVP & CIO
|
GiftCommon Stock | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-19-000153 · wf-form4_155474967555852.xml · nonDerivative · entry 2 Shah Aarti S. · CIK 0001725292 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,320 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.